Avoid repeated temperature fluctuations
A 2025 preliminary safety study administered intravenous BPC-157 to 2 participants at escalating doses with no adverse effects reported, but the extremely limited sample size prevents meaningful conclusions
Full chart for BPC-157, TB-500, GHK-Cu, semaglutide, tirzepatide, and retatrutide
Pricing is transparent with no hidden fees
Caution is advised in those with severe respiratory or pulmonary diseases, especially in those with chronic oxygen tank dependence
We dont know whether the participants were B12 deficient and were being made B12 replete, or whether they were B12 replete to start with and this was additional B12, which would be important to know if you did think that this were an effective therapy. Dr Whittle said there were some effective pharmacotherapies for fibromyalgia such as duloxetine or pregabalin